Exagen GAAP EPS of -$0.31 misses by $0.15, revenue of $17.24M beats by $0.34M
Source: SeekingAlpha
2025-11-04 08:09:31 ET
More on Exagen
- Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now
- Seeking Alpha’s Quant Rating on Exagen
- Historical earnings data for Exagen
- Financial information for Exagen
Read the full article on Seeking Alpha
For further details see:
Exagen GAAP EPS of -$0.31 misses by $0.15, revenue of $17.24M beats by $0.34M
Exagen Inc.
NASDAQ: XGN
XGN Trading
-8.28% G/L:
$3.12 Last:
260,124 Volume:
$3.17 Open:
XGN Latest News
February 24, 2026 09:00:00 am
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
XGN Stock Data
$80,000,739
13,869,817
3.15%
15
N/A
Medical Diagnostics & Screening
Healthcare
US
Vista
